13F Data
13F filer · CIK 1545692

NVP ASSOCIATES, LLC

MENLO PARK, CA · filing since Q4 2022 · last filing Aug 7, 2026
Reported value
$328.2M
+$152.0M vs prior
Positions
7
New / sold out
3 / 1
Added / reduced
0 / 0
Turnover
16.1%
buys $104.0M · sells $40.5M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewAVALYN PHARMACEUTICALS INC+2,268,404–+$74.7M
NewSNOWFLAKE INC+114,786–+$29.2M
NewONDAS INC+15,602–+$128.6K

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outBILLIONTOONE INC-513,330-100.0%$-40.5M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2022: $102.5MQ1 2023: $86.9MQ2 2023: $114.6MQ3 2023: $111.7MQ4 2023: $112.1MQ1 2024: $125.9MQ2 2024: $91.3MQ3 2024: $176.1MQ4 2024: $186.9MQ1 2025: $112.2MQ2 2025: $184.2MQ3 2025: $166.1MQ4 2025: $255.2MQ1 2026: $176.2MQ2 2026: $328.2M
Q4 2022Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1MBX BIOSCIENCES INCCOM2,136,335$117.9M35.93%
2AVALYN PHARMACEUTICALS INCCOM SHS2,268,404$74.7M22.75%
3OMADA HEALTH INCCOM2,531,000$55.6M16.93%
4ZENAS BIOPHARMA INCCOM1,838,482$46.7M14.22%
5SNOWFLAKE INCCOM SHS114,786$29.2M8.90%
6GROVE COLLABORATIVE HOLD INCCOM CL A3,225,097$4.0M1.23%
7ONDAS INCCOM NEW15,602$128.6K0.04%